Reinvigorating the concept of benefit: the failure of drug company-sponsored research on human subjects.
Fox
Jacqueline
J
University of South Carolina School of Law, USA.
D000293:Adolescent; D035843:Biomedical Research / Q000191:economics* / Q000941:ethics / Q000266:history / Q000639:trends; D002648:Child; D003362:Cost-Benefit Analysis; D003866:Depressive Disorder / Q000188:drug therapy; D030881:Disclosure / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics*; D005378:Financial Support; D049673:History, 20th Century; D006805:Human Experimentation / Q000941:ethics / Q000266:history / Q000331:legislation & jurisprudence*; D006801:Humans; D015279:Organizational Culture; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D012941:Social Responsibility; D014481:United States; D014486:United States Food and Drug Administration
D017367:Selective Serotonin Reuptake Inhibitors